| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.067 | 0.6 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.6 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.18 | 0.6 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |